371 related articles for article (PubMed ID: 35904817)
1. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
2. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X
J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980
[TBL] [Abstract][Full Text] [Related]
5. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
[TBL] [Abstract][Full Text] [Related]
6. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
[TBL] [Abstract][Full Text] [Related]
7. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
8. Genistein Regulates Lipid Metabolism via Estrogen Receptor β and Its Downstream Signal Akt/mTOR in HepG2 Cells.
Qin H; Song Z; Shaukat H; Zheng W
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836271
[TBL] [Abstract][Full Text] [Related]
9. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
10. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
11. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
12. Akt Serine/Threonine Kinase 1 Regulates de Novo Fatty Acid Synthesis through the Mammalian Target of Rapamycin/Sterol Regulatory Element Binding Protein 1 Axis in Dairy Goat Mammary Epithelial Cells.
Zhang T; Huang J; Yi Y; Zhang X; Loor JJ; Cao Y; Shi H; Luo J
J Agric Food Chem; 2018 Feb; 66(5):1197-1205. PubMed ID: 29323924
[TBL] [Abstract][Full Text] [Related]
13. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
14. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic avian reovirus σA-modulated fatty acid metabolism through the PSMB6/Akt/SREBP1/acetyl-CoA carboxylase pathway to increase energy production for virus replication.
Hsu CY; Chen YH; Huang WR; Huang JW; Chen IC; Chang YK; Wang CY; Chang CD; Liao TL; Nielsen BL; Liu HJ
Vet Microbiol; 2022 Oct; 273():109545. PubMed ID: 35998542
[TBL] [Abstract][Full Text] [Related]
18. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
19. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
20. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]